Proposal of a population wide genome-based testing for Covid-19

Hans Lehrach1,2, Jon Curtis3, Bodo Lange3

  • 1Alacris Theranostics GmbH, Berlin, Germany. lehrach@molgen.mpg.de.

Scientific Reports
|April 5, 2022
PubMed
Summary

A novel, low-cost, highly sensitive PCR-based test for SARS-CoV-2 (COVID-19) genome detection could control the pandemic. Systematic, repeated population-wide testing offers a feasible strategy for managing COVID-19.